C000237308 Performance — Putnam BioRevolution ETF
Data updated: 2025-12-29
C000237308 returned −0.57% over one year to Oct 2025. The annualised 3-year return is +7.03%. The fund trailed its US Large Growth category average: $100 invested three years ago grew to $123, against $201 for the category, and to $99 over one year, against $124. Volatility over the past three years was 15.12% a year. In the 12 months to Oct 2025 the fund lost a net $792K, and assets reached $4.66M.
C000237308 Growth of $100
What $100 invested in Putnam BioRevolution ETF grew to, compounded from monthly returns reported on SEC Form N-PORT, against the US Large Growth category average over the same months.
| Period | C000237308 | Category average |
|---|---|---|
| 1 year (Nov 2024 – Oct 2025) | $99 | $124 |
| 3 years (Nov 2022 – Oct 2025) | $123 | $201 |
| Since data start (Aug 2022 – Oct 2025) | $127 | $193 |
C000237308 Trailing Returns
Total returns to Oct 2025, from SEC N-PORT.
| Period | Total return |
|---|---|
| 1 year | −0.57% |
| 3 years (annualised) | +7.03% |
C000237308 Annual Returns
Calendar-year total returns of Putnam BioRevolution ETF, compounded from monthly SEC N-PORT returns. Partial years show the months covered.
| Year | Total return |
|---|---|
| 2025 (Jan–Oct) | +0.14% |
| 2024 | +19.19% |
| 2023 | +2.63% |
| 2022 (Aug–Dec) | +3.44% |
C000237308 Monthly Returns
Monthly total returns as reported on SEC Form N-PORT.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | −0.9% | −1.0% | −5.0% | −4.3% | +2.2% | +3.1% | −0.8% | +5.0% | −1.4% | +3.7% | — | — |
| 2024 | +8.9% | −5.3% | +2.5% | +5.9% | +3.5% | +1.1% | +5.1% | −4.8% | +0.3% | +2.2% | +3.9% | −4.5% |
| 2023 | +7.3% | +0.6% | +3.5% | −4.0% | +3.2% | +4.0% | −2.9% | −7.0% | −6.0% | −0.8% | −1.9% | +7.8% |
| 2022 | — | — | — | — | — | — | — | +3.4% | — | — | +5.8% | −5.4% |
C000237308 Risk
Risk measures from monthly returns over Nov 2022 – Oct 2025.
- 3-year volatility (annualised): 15.12%
- 3-year Sharpe ratio: 0.17 (vs 4.5% risk-free rate)
- Best month: +8.86% (Jan 2024)
- Worst month: −6.96% (Aug 2023)
C000237308 Fund Flows
Monthly money in and out of Putnam BioRevolution ETF, from SEC Form N-PORT.
- 12-month net flow: −$792K
- 12-month gross sales (incl. reinvestments): $73
- Sales ÷ redemptions: 0.00×
| Month | Sales | Redemptions | Net flow |
|---|---|---|---|
| Oct 2025 | $73 | $792K | −$792K |
| Sep 2025 | $0 | $0 | $0 |
| Aug 2025 | $0 | $0 | $0 |
| Jul 2025 | $0 | $0 | $0 |
| Jun 2025 | $0 | $0 | $0 |
| May 2025 | $0 | $0 | $0 |
| Apr 2025 | $0 | $0 | $0 |
| Mar 2025 | $0 | $0 | $0 |
| Feb 2025 | $0 | $0 | $0 |
| Jan 2025 | $0 | $0 | $0 |
| Dec 2024 | $0 | $0 | $0 |
| Nov 2024 | $0 | $0 | $0 |
C000237308 Assets Under Management
Net assets of Putnam BioRevolution ETF by report date, from SEC N-PORT filings.
| Report date | Net assets |
|---|---|
| 2025-10-31 | $4.66M |
| 2025-07-31 | $5.07M |
| 2025-04-30 | $4.85M |
| 2025-01-31 | $5.39M |
| 2024-10-31 | $5.51M |
| 2024-07-31 | $5.65M |
| 2024-04-30 | $5.14M |
| 2024-01-31 | $5.00M |
| 2023-10-31 | $4.35M |
| 2023-07-31 | $5.01M |
| 2023-04-30 | $4.80M |
| 2023-01-31 | $4.80M |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.